HYOF), the London-based brain imaging company, has expanded its partnership with the Global Alzheimer's Platform Foundation (GAP) in a deal that gives it access to one of the world's largest Alzheimer's biomarker datasets. The company said on Tuesday it had secured full data usage rights for GAP's Bio-Hermes-002 study, an influential research programme aimed at speeding up the use of new Alzheimer's biomarkers in clinical trials. 